Quantcast
Channel: EURACTIV PR
Viewing all 7168 articles
Browse latest View live

Medicines for Europe to join the ISPOR Issue Panel on value added medicines

$
0
0
Health & Consumers

 

 

 

 

 

 

 

 

  • The Issue Panel at the ISPOR European Congress in Glasgow on 6 November ‘Value Added Medicines: Time to Adjust the Health Technology Assessment Decision Frameworks?’ will debate how patients can benefit from value added medicines.
  • Value added medicines are medicines which are based on 3 drug repurposing models: reformulation, repositioning or a combination of known molecules, which deliver substantial value for patients and society.
  • HTA decision-making in Europe presents challenges for full value added recognition of these medicines. Addressing ways to recognise patient-centric innovation in value assessment frameworks is crucial for the assessment of value added medicines.

Value added medicines represent a major opportunity to improve patients’ quality of life, health outcomes or adherence, and to address a number of medicine-related healthcare inefficiencies, improving healthcare provision and organisation while contributing to the sustainability of healthcare systems.

To ensure access to value added medicines for patients, the Value Added Medicines Group, a sector group of Medicines for Europe, will participate in the ISPOR 20th Annual European Congress  on an Issue Panel entitled “Value Added Medicines: Time To Adjust The Health Technology Assessment Decision Frameworks?”.

Moderated by Professor Michael Drummond (Professor of Health Economics at the Univerity of York), the panellists (Professor Mondher Toumi from the Public Health Department of Aix-Marseille University, Professor Ulf Persson from the Swedish Institute of Health Economics and Luigi Burgio – Head of Market Access Teva Italy and Chairman of the HTA Working Group at Medicines for Europe) will debate current challenges for capturing the benefits of value added medicines as well as key recommendations to integrate and recognise patient-centric innovation in HTA decision frameworks.

Umberto Comberiati, the Chairman of the Value Added Medicines Group,: “Thetime has come to explore new areas to deliver better health and access for patients, tapping into a sustainable source of patient-centric innovation. Value added medicines are an opportunity to deliver benefits to patients, payers and healthcare systems. However, there is a challenge to ensure that benefits can be appropriately assessed  via HTA decision frameworks. The ISPOR Issue Panel will allow an informed debate among experts, industry and stakeholders.

Medicines for Europe invites you to join the ISPOR European Congress in Glasgow and please follow us on Twitter and LinkedIn to know more about how European patients can better benefit from value added medicines. More information on the Issue Panel and the challenges and recommendations on adjusted HTA decision frameworks for value added medicines can be found here.

 

About the Value Added Medicines Group

The Value Added Medicines Group is a sector group of Medicines for Europe which aims to optimise, rethink and reinvent medicines based on known molecules and to bring untapped innovation to improve care delivery. The Value Added Medicines Group adopts a complementary perspective compared to the other Medicines for Europe sector groups: by tackling the targeted portion of patients’ needs that remain unmet to this day, delivering additional improvement to the healthcare community as a whole.

 

About Medicines for Europe

Medicines for Europe represents the generic, biosimilar and value added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership. Its members employ 160,000 people at over 350 manufacturing and R&D sites in Europe, and invest up to 17% of their turnover in medical innovation.

 

About About ISPOR

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a non-profit, international, educational and scientific organisation that promotes health economics and outcomes research excellence to improve decision making for health globally.

 

05 Oct 2017

How Steel Packaging Contributes to Saving Food

$
0
0
Agriculture & Food

4 October 2017

A new film from APEAL, the Association of European Producers of Steel for Packaging, has been launched to highlight the unique preservation qualities of steel packaging.

Having recently welcomed the European Parliament’s (EP) initiative report – Resource efficiency: reducing food waste, improving food safety – APEAL is increasing its own efforts to drive improvements in managing food waste at all stages in the supply chain.

The film, which highlights the increased product shelf life and convenience of food packed in steel, forms part of a new campaign from APEAL: Less haste, save taste cut waste.

https://www.apeal.org/food-waste/

“The positive contribution of packaging as a solution to the prevention of loss and waste along the supply chain has been recognised following the EP report,” commented Alexis Van Maercke, secretary general of APEAL.

“The challenge today is to ensure this message reaches as wide an audience as possible.”

88 million tonnes of food are wasted each year in Europe (EU Fusions 2016 report). Making the right packaging choices is fundamental if the EU is to reach its commitment to halve per capita food waste at retail and consumer level by 2030. 

“No other packaging material equals steel’s strength, total barrier properties or shelf life. As a result, food packed in steel retains nutrients, appearance and flavour, and is less likely to be damaged, spoiled, or unnecessarily wasted,” added Van Maercke.

The latest recycling figures from APEAL confirmed that with 77.5% recycled in 2015 1, steel is the most recycled packaging material in Europe reinforcing its continued contribution to wider environmental and resource efficiency objectives.

Steel for Packaging – fact file

Preventing food waste throughout the supply chain:

  • Canned fruit and vegetables are most often harvested at their peak of ripeness and canned in as little as 4 hours, minimising product loss at processing
  • Misshapen or “ugly” food can be canned and processed as normal, minimising product loss at processing and retail
  • Steel’s strength and 100% barrier against light, water and air protects food, minimising product loss during transport, retail and storage
  • Portion sized packaging allows consumers to buy the precise quantity needed, minimising product loss at consumption.

Ends

 

Media enquiries:

Will Herman

Pelican Communications

Email: will.herman@pelicomms.co.uk

00 +44 (0)1457 820807

 

APEAL:

Patricia Mobbs

Communications Manager

E-mail: p.mobbs@apeal.be

www.apeal.org

www.steelforpackaging.org

 

About APEAL

APEAL - the Association of European Producers of Steel for Packaging is a federation of four multi-national producers of steel for packaging (ArcelorMittal, Tata Steel, thyssenkrupp Rasselstein, U.S. Steel Košice). In total these four companies employ over 200,000 workers in Europe. Founded in 1986, APEAL represents today about 95% of the total European production of steel for packaging.

 

About Steel for Packaging

Steel is a unique packaging material, combining exceptional performance capabilities with unrivalled environmental credentials. Strong, formable and long-lasting, steel offers numerous benefits for the safe packaging of a wide variety of products.

1 APEAL recycling rate figure for EU 28 counties + Norway & Switzerland

05 Oct 2017

Regionalverband FrankfurtRheinMain

The Week Ahead from the ECR Group in the European Parliament - 9th October - 13th October 2017

$
0
0

Sakharov prize shortlist
On Tuesday the foreign affairs and development committees will hold a joint meeting to shortlist three candidates for this year's Sakharov Prize for Freedom of Thought. The prize is awarded each year by the European Parliament and was set up in 1988 to honour individuals and organisations defending human rights and fundamental freedoms. The ECR Group have nominated Asia Bibi (Aasiya Noreen), a Pakistani Christian woman sentenced to death in 2010 under the country´s blasphemy law and currently on death row. ECR MEPs Peter Van Dalen, Anna Fotyga and Tomasz Poreba have long campaigned for Bibi's release whose appeal to Pakistan's supreme court has been postponed to an undetermined date.

When: Tuesday @ 17:00
Press officer to contact: Gareth Goldsmith +32 476 668 050, gareth.goldsmith@ep.europa.eu

Terrorism committee begins it work
Parliament's special committee on terrorism meets for the first time on Wednesday. ECR Flemish MEP Helga Stevens has been appointed co-rapporteur of the committee's final report our group want this committee to find practical solutions on how to better protect our citizens and create better cooperation between law enforcement authorities in the EU.

When: Wednesday @ 14:00
Press officer to contact: Yannick Vanderveeren +32 473 806 446,  yannick.vanderveeren@ep.europa.eu

Militarisation of black sea
The security and defence committee will hold a public hearing on militarisation in the Black Sea on Wednesday. The regional security situation has become increasingly challenging for the EU and NATO and the hearing will focus on the security situation following Russia's illegal annexation of Crimea and the conflict in Eastern Ukraine. Furthermore, the hearing will analyse the military and strategic consequences of the conflicts and the possibilities to foster stability and cooperation.

When: Wednesday @ 14.40, PHS 5B001
Press officer to contact: Marta Lipinska, +32 470 904 337, marta.lipinska@ep.europa.eu

EU-New Zealand and EU-Australia
Members of the international trade committee are expected to approve draft reports on Thursday on the proposed negotiating mandate for trade talks with Australia and New Zealand. ECR Co-ordinator Emma McClarkin and Deputy Co-ordinator David Campbell Bannerman are shadow rapporteurs. Meanwhile, a report by ECR Foreign Affairs Co-ordinator Charles Tannock on a partnership agreement between the EU and New Zealand will be voted on by the Foreign Affairs Committee on Tuesday.

When: Foreign Affairs - Tuesday 9am; International Trade - Thursday 9am
Press Officer to contact: Robert Taylor +32 498 984760, robert.taylor@ep.europa.eu

 

The ECR was created to take the EU in a new direction, according to the principles of our founding Prague Declaration. It is the third largest group in the European Parliament with 74 MEPs from 18 EU states.

For more information on the ECR, watch our promotional video at http://youtu.be/F5syQt1JuQI or visit our website: www.ecrgroup.eu

06 Oct 2017

Global Perspectives On Health in All Politics

$
0
0
Health & Consumers

Friday 6 October 2017

The closing press point of the EHFG 2017 highlighted the global angle to “Health in All Politics”, the Forum’s main theme. Featuring Vytenis Andriukaitis, European Commissioner for Health and Food Safety, Andrea Ammon, Director of the European Centre for Disease Prevention and Control, and Agneta Karlsson, State Secretary of the Swedish Ministry of Health and Social Affairs, the press point covered a wide range of issues, with the discussion touching upon vaccination, antimicrobial resistance, multimorbidity, and the important role of social determinants in improving health and well-being.

***

The speakers at today’s press point:

  • Vytenis Andriukaitis, European Commissioner for Health and Food Safety
  • Andrea Ammon, Director of the European Centre for Disease Prevention and Control
  • Agneta Karlsson, State Secretary of the Swedish Ministry of Health and Social Affairs

 

Vytenis Andriukaitis – European Commissioner for Health and Food Safety

I am very pleased to be back in Gastein for the fifth time.

I am delighted that this year's theme is 'Health in all Politics'. Our aim must be to get all policies, all Ministers, all stakeholders, at all levels, to contribute to keeping people in good health. Education, marketing, taxation, urban planning can all help foster healthy living. Global Health is another issue on the Gastein agenda this year. I hope to seize on the Sustainable Development Goals (SDGs) to raise the profile of global health.

The Commission is preparing an initiative to support vaccination, which we will present next year (2018), to support Member States in increasing vaccination coverage, fighting vaccine hesitancy and addressing problems with vaccine supply and production.

Vaccines are one of the safest and most cost-effective ways to ensure public health and avoid preventable disease. It is therefore my honour to announce the shortlist of 10 outstanding initiatives by NGOs which have significantly contributed to higher levels of vaccination in the EU population. I will give the award for the three top prizes during the EU Health Policy Platform Meeting on 27 November 2017, but from my point of view, all 10 NGOs are winners.”

The 10 shortlisted initiatives of the EU Health Award for NGOs 2017, announced at the European Health Forum Gastein 2017, can be found here.

***

Andrea Ammon – Director, European Centre for Disease Prevention and Control

“Vaccination is a major priority for the ECDC. Vaccine hesitancy is an issue that threatens the success of vaccines we have seen. This is why we developed communication tool kits to help doctors deal with questions of parents. The bottom line is that all parts of society have to be involved to find a solution.”

In identifying infectious threats in Europe, ECDC has a global role to play, because -when it comes to infectious threats- nothing is remote. Every morning ECDC do an assessment of rumours and threats around all infectious diseases and warnings of rumours will be posted on social media.

It is absolutely necessary to have a global network of monitoring media and to have an early warning system to flag rumours. As discussed in the EHFG workshop yesterday, the first pilot projects taking the rumour monitoring will require further assessment. ECDC is looking to involve behavioural scientists to help assess the behaviour behind the rumours so that we can develop counter measures.”

***

Agneta Karlsson - State Secretary, Swedish Ministry of Health and Social Affairs

“Global health and health in all politics are extremely important to build a society that holds together. The work around the 2030 agenda provides positive momentum for lifting up and enforcing the work on global health and “Health in All Politics”.

In Sweden, we have been working on “Health in All Politics” for a long time, with inclusion being a key objective. But that is not enough. If we really want to make progress and to make everyone included, we need to find a way to integrate equality in all policies. For this, social determinants are important. With our own Commission on Social Determinants, we found conditions in early life are particularly important: schools, vaccination schemes, good maternity health services, and educational opportunities throughout life. We also need to make sure that people have the ability to be economically independent. To make everyone have a good life, we need to take into account “Health in All Politics” in all life cycles. This is not only a matter of healthcare ministers.

Vaccine prevention is very important. Sweden has a high rate of vaccination among children, but we also see that misunderstandings and rumours can move around quite quickly. One thing we can do is to give more money to our public health agencies for awareness raising campaigns. We need to work together on this, both at the European level and the national level.”

 

 

If you have any questions or comments, please feel free to contact:

European Health Forum Gastein 2017 – Press office
 

E: press@ehfg.org

T: +32 2 321 90 16
 

06 Oct 2017

DAFNE - Donors and Foundations Networks in Europe

DAFNE strengthens its presence in Brussels

$
0
0
Brussels – 6 October 2017. DAFNE (Donors and Foundations Networks in Europe) is pleased to announce the appointment of Max von Abendroth as its Brussels-based Executive
Director as from 1st October 2017.
 
“This significant addition to our team will strengthen our strategic and mutually supportive relationships with relevant organisations in Brussels, ensuring the national reach and breadth of the donor and foundation membership base of our 25 national associations enhances the effectiveness of advocacy work for the foundation sector across Europe”, said DAFNE Chairman Felix Oldenburg, CEO of Bundesverband Deutscher Stiftungen in Germany.
“With a permanent representative in Brussels we will be able work more closely with the European Foundation Centre (EFC) and others to strengthen our collective voice in Brussels
to inform positive developments and address and mitigate against legislative initiatives that could potentially undermine the effectiveness of philanthropy in Europe.”
 
Max has been working since 2009 as the Executive Director of the European Magazine Media Association, EMMA, in Brussels, representing 15.000 press publishers across Europe
vis-à-vis the European institutions. In 2012 Max initiated the Future Media Lab. think tank linking media innovation and public policy. He was co-founder and director of the start-up “Accelerating European Media Innovation and Insight”, AEMII. Max sits on the Board of Fondation EURACTIV #Media4EU.
 
Gerry Salole, Chief Executive of the European Foundation Centre, welcomes the appointment of Max von Abendroth: “Max brings a wealth of experience of managing and
representing a European network, in the field of media, he will be a great asset to Europe’s foundation sector. I am looking forward to further developing our collaboration with DAFNE in order to help improve the operating environment for institutional philanthropy.”
 
“I am very much looking forward to join DAFNE at this crucial moment, when it is forming a competent and impactful interest representation alliance for Europe’s foundation sector” says Max von Abendroth, recently appointed DAFNE Executive Director.
 
--ENDS—
06 Oct 2017

The theme “Health in all politics” dominated European Health Forum Gastein 2017 as a solution to health inequalities

$
0
0
Health & Consumers
  • Around 500  leading European health policy experts from the worlds of policy-making, research, civil society and business debated today’s main health policy challenges over three days at Gastein.
  • Participants got to grips with a wide and complex range of issues surrounding health inequalities and the need for broad political engagement and decisive action at all levels.      
  • On the Forum’s 20th anniversary they explored future scenarios for improving health in Europe in 2037 and reshaping how this unique policy forum needs to evolve.

Bad Hofgastein, Austria, 6 October 2017. After three days of forward-looking and intense discussion on the future of health in Europe, the 20th European Health Forum Gastein “Health in All Politics – a better future for Europe” ends today.

Politicians and researchers at this leading health policy forum gave, for example, details of the Estonian and Austrian EU Presidency priorities on key issues such as harmful use of alcohol, ehealth, and nutrition.

On the last day of the Forum, European Commissioner for Health and Food Safety, Vytenis Andriukaitis announced the 10 initiatives that have made it on the shortlist for the EU Health Award for NGOs 2017, which aims to reward Non-Governmental Organisations that have contributed to a higher level of public health in the EU through promoting vaccination. (See here and here).

This year’s EHFG programme created a platform to air concerns about rising costs of healthcare provision, and waste within health systems.  Equally, concerns to provide patients with the innovative medicines they need now dominate the political agenda at all levels. A number of Forum sessions examined the costs of innovative medicines, pointing out that already tight budgets are being put under further strain.

UK researchers used the Forum to launch a new study on the “Availability of evidence on overall survival and quality of life benefits of cancer drugs approved by the European Medicines Agency. Patients highlighted the realities of health inequalities associated with “post-code lotteries” when health authorities make choices on which medicines are available to patients. At the same time, the pharmaceutical industry sees itself confronted with mounting pressure to reduce the prices of these life-saving therapies, which are often the product of years of investment, research, and development.

Various solutions to address this problem were debated. Some called for thinking outside the box by pursuing the health angle in other areas of policy-making. Others explained the need to strike the right balance between sellers and buyers of medicines: ensuring meaningful patient engagement in innovation in all its guises becomes key to ensuring valuable innovation that addresses unmet need.

For many, the source of the problem was health inequalities that must be addressed. One session dedicated to the topic heard the powerful message that “inequalities should not be seen as a footnote to the problems that we face, they are the problems that we face”. Solutions were to be found by shifting power, wealth and resources through a multi-stakeholder approach involving academia, the public health community, regulators, and industry at all levels of government. Civil society was viewed by some as being crucial to holding governments to account. The public health community could also do more by engaging more in discussions on economic issues, e.g. in ensuring health figures in international trade agreements talks.

The role of politicians in making health policy recommendations and informed but often tough choices across all government activities was how many participants identified with the theme “Health in all Politics”.

Clemens Martin Auer, Director General of Austria’s Federal Ministry of Health and Women’s Affairs and EHFG President explained: “The world has become complex; at policy level we need some flexibility. At political level we have a box of tools. We must do more matchmaking among ministers, getting ministers of health talking to ministers of science about public investment in R&D.” (See here and here).

The Forum highlighted how cities and regions, where local politicians are often closer to citizens, could show how urban health can be improved. (See here). But it also recognised the role of the European Commission with calls for its health competence to be strengthened. Global considerations were also seen to be important in shaping our response to better health, with references Sustainable Development Goals as well steps to modernize the World Health Organization and the UN system at large.

Whether on the sensitive topic of access to medicines and innovation, or on how to embrace big data and ICT, EHFG demonstrated its value in creating an environment for people to talk “to” each other and not “past” each other. With a degree of consensus around the view that fundamental access and inequity challenges facing Europe today, need a collaborative, solution-oriented mind-set involving all stakeholders, at all levels of government from local to global, with above all a real sense of urgency.  (See here).

As the new EHFG President, Mr Auer shared his vision of the role the Forum can enact in tackling the many topics facing those involved in health policy making: “we need to start transforming ideas into implementation, become a test lab for ideas for a new kind of implementation dialogue that looks at the how”.  Building on the 20-year legacy of EHFG as an environment conducive to a balanced and civilised debate, he explained there was a need to be creative and overcome silo working, fragmentation and promote interoperability. He warned that “there is no creativity without confrontation, but we can build on a strong foundation of trust”.

Change and the degree to which we can prepare for the future underpinned many sessions. The topic of Big Data and technological innovation highlighted how the health landscape is changing, offering exciting vistas of how access to digital technologies can make societies more efficient and bring people together by providing value-added services. (See here). But Big Data and digital transformation can re-enforce disparities, be disruptive and make us rethink our perspectives on ethics and quality of care. Indeed, one of the “health future” scenarios for 2037 was based on looking at how technology can create a new vision of better health for Europe.

Dorli Kahr-Gottlieb, Secretary General of EHFG, presented the “Health Futures Project” looking to scenarios for better health futures twenty years ahead. Upon learning that 5% of Estonia’s population know their genomes, she commented on “how some aspects of the futures thinking presented in the scenarios were already reality in some parts of Europe”. (See report here).

“This demonstrates clearly that Europe’s diversity is a huge strength, and the Forum’s goal of sharing and drawing lessons from health policy successes and failures is hugely important for fast-tracking much-needed solutions to ensuring a better health for Europe.”

***

 

Note to the editors

About the European Health Forum Gastein

The European Health Forum Gastein (EHFG) was founded in 1998 as a European health policy conference. It aims to provide a platform for all stakeholders from the field of health and beyond. Over the past decade, the EHFG has established itself as an indispensable institution in the broad field of European health policy. It has made a decisive contribution to the development of guidelines and above all the cross-border exchange of experience, information and cooperation. Leading experts participate in the annual conference held in the Gastein Valley in the Austrian Alps for three days in October.

EHFG media releases 2017

PRESS RELEASE: 20th edition of European Health Forum Gastein 2017 opens its doors tomorrow

https://www.ehfg.org/fileadmin/downloads/21-press/2017/docs/Press_Release_EHFG_2017.pdf

 

PRESS RELEASE: European Health Award 2017 goes to Gen-Equip project https://www.ehfg.org/fileadmin/downloads/21-press/2017/docs/Press_Release_-_Winner_Short.pdf

 

PRESS POINT: Health in all politics

https://www.ehfg.org/fileadmin/downloads/21-press/2017/Press_Release_Health_in_All_Politics.pdf

 

PRESS POINT: Local Health for Politics

https://www.ehfg.org/fileadmin/downloads/21-press/2017/EHFG_2017_Press_Point.pdf

 

MEDIA ADVISORY: Access to medicines and innovation

https://www.ehfg.org/fileadmin/downloads/21-press/2017/Media_Advisory.pdf

 

MEDIA ADVISORY: Big data

https://www.ehfg.org/fileadmin/downloads/21-press/2017/Big_Data.pdf

 

PRESS POINT:  Global perspectives on health in all politics

https://www.ehfg.org/fileadmin/downloads/21-press/2017/EHFG_2017_Press_Point_Friday_6_October.pdf

 

20 YEARS EHFG

https://www.ehfg.org/about-us/20-years/

 

If you have any questions or comments, please feel free to contact:

European Health Forum Gastein 2017 – Press office
E: press@ehfg.org T: +32 2 321 90 16

06 Oct 2017

Fünfte Runde der Brexit-Verhandlungen – Zeit für Ergebnisse

$
0
0
UK in Europe

Frankfurt, 9. Oktober 2017 – Die Zeit für einen geordneten Brexit wird immer knapper. Der deutsche Maschinenbau appelliert daher an beide Seiten, in der heute beginnenden fünften Verhandlungsrunde endlich Ergebnisse zu den Details des Austritts Großbritanniens aus der EU zu liefern. Aus Sicht des VDMA können Übergangsregelungen ab März 2019 erforderlich werden, um mehr Zeit für die Einigung auf ein Folgeabkommen zu haben.

„Ein harter Brexit ist ein denkbares, aber für die Wirtschaft kein akzeptables Szenario. Weil das insbesondere für das Vereinigte Königreich risikoreich wäre, besteht Hoffnung, dass ein solches Szenario vermieden wird. Wenn die Zeit für die Einigung auf ein Folgeabkommen zu knapp wird, muss man Übergangsregelungen ab März 2019 grundsätzlich in Betracht ziehen“, sagt Thilo Brodtmann, Hauptgeschäftsführer des VDMA. „Es ist eindeutig, dass vor allem Großbritannien realistischere Erwartungen an den Brexit und die Zeit danach entwickeln muss. Die EU darf und wird sich in den Verhandlungen nicht verbiegen, weil für die heimischen Unternehmen der Erhalt des Binnenmarktes Priorität hat. Allerdings hat die britische Premierministerin Theresa May mit ihrer Rede in Florenz zuletzt Kompromissbereitschaft gezeigt. Das ist ein positives Zeichen, das die EU-Kommission ernst nehmen sollte.“

Für den deutschen Maschinenbau ist Großbritannien der viertwichtigste Auslandsmarkt weltweit mit einem Exportvolumen von 7,4 Milliarden Euro (2016). Umgekehrt lieferte das Vereinigte Königreich 2016 Maschinenbauprodukte im Wert von 2,4 Milliarden Euro nach Deutschland.

09 Oct 2017

BBMRI-ERIC - The Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium

GDPR Code of Conduct for Health Research and Implications for FP9

$
0
0
Health & Consumers

Brussels, 9 October 2017 – The Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium (BBMRI-ERIC) is hosting a seminar to assess the impact of the GDPR on FP9 health research and examine how the Code of Conduct for Health Research being developed by BBMRI-ERIC and collaborators will address future health challenges. The seminar will take place on 6 November 2017 in Brussels.

Preparations for FP9 (2021-2027) has begun and the European Commission is expected to publish its initial proposal in the first half of 2018. Discussions on the programme’s structure, content, and budget are under way covering sustainability, socio-economic impact, and the use and management of data created by pan-European research infrastructures, including the contribution of these infrastructures to health sciences and research. The General Data Protection Regulation (GDPR) will apply across the EU from 25 May 2018. Articles 40 and 41 of the GDPR are the primary sources of authority for establishing approved codes of conduct to serve as compliance tools for data controllers and processors. Following a series of exploratory meetings in 2017, BBMRI-ERIC has launched a forum to develop a GDPR Code of Conduct for Health Research as the means to comply and to contribute to the proper implementation of GDPR. Through the forum, BBMRI-ERIC is engaging with approximately 80 key stakeholders and a drafting group from across the EU, to outline the GDPR Code of Conduct for Health Research. This code will be vital for enabling and advancing collaborative health research following the application of the GDPR.

The seminar on 6 November 2017 will focus on how the new data protection environment will determine and affect the use of (sensitive) personal data for health sciences in future research collaborations. The seminar will also help participants to understand the policy context for FP9 and how this will be impacted by the GDPR and other regulations, including those covering medical devices and clinical trials. The seminar will also include discussions on how the programme might address biological and medical science research, including the use of sensitive personal data, for the programme to deliver benefits for the EU’s citizens and economy.

The seminar sessions will cover big data and the European Open Science Cloud, GDPR and the Code of Conduct for Health Research, and FP9. Speakers will include:

  • Jan-Eric Litton, Senior Advisor, BBRMRI-ERIC;
  • Michaela Th. Mayrhofer, Chief Policy Officer, BBMRI-ERIC;
  • Augusto Burgueno Arjona, Head of Unit, European Commission;
  • Magali Poinot, Advisor to the Executive Director, IMI2;
  • Brendan Barnes, Director Data protection, IP & Global Health, EFPIA;
  • Lydia Makaroff, Director, European Cancer Patient Coalition;
  • Nathalie Bertels, Big Data Value Association.

 

The seminar will take place on Monday, 6 November 2017, from 10h00 to 16h00 at Science 14, 14b Rue de la Science, Brussels B-1040 (map: https://goo.gl/maps/6DQhCYURwrQ2).

Registration is available is available at http://iscintelligence.com/event.php?id=322.

 

For further information on the 6 November seminar, please contact:

Tjaša Petročnik, Policy analyst, ISC Intelligence in Science

Email: tjasa.petrocnik@iscintelligence.com

Tel: +32 2 880 36 24

 

For BBMRI-ERIC media enquiries, please contact:

Luc Deltombe, Communication and Finance Assistant, BBMRI-ERIC

Email: luc.deltombe@bbmri-eric.eu

Tel: + 43 316 34 99 17 21

 

Declan Kirrane, ISC Intelligence in Science

Email: declan.kirrane@iscintelligence.com

Tel: + 32 494 34 60 40

 

For further information on BBMRI-ERIC, please contacts  Michaela Th. Mayrhofer at michaela.th.mayrhofer@bbmri-eric.eu.

 

Editor’s note

Previous meetings on the GDPR Code of Conduct for Health Research:

Implementation of the General Data Protection Regulation (GDPR), which will apply from 25 May 2018, will encourage EU organisations to draw up a code(s) of conduct so that they can contribute to the proper application of the GDPR in specific sectors and can demonstrate compliance with the GDPR. A code(s) may be prepared by associations or representative bodies for the approval, registration, and publication by a supervisory authority.

The GDPR Code of Conduct for Health Research will help guide researchers and administrative staff, will reduce unnecessary fear about compliance, and enhance data sharing for the progress of health research.

Since early 2017, BBMRI-ERIC has held multiple working meetings on this topic.

On 1 February 2017, BBMRI-ERIC hosted a working meeting in Brussels, bringing together around 30 representatives from the European biological and medical science research infrastructures, policy-makers, medical and health associations, industry representatives, patient advocacy groups, and other interested stakeholders. The aim was to express commitment to be involved in developing the code as well as to discuss and develop a roadmap for a harmonised Code of Conduct for Health Research. The February meeting concluded with a common agreement that it would be good to develop a code of conduct and to have a transparent consultation process. More information is available at: http://iscintelligence.com/event.php?id=310.

On 7 June 2017, in Brussels, BBMRI-ERIC organized a forum to present the governance concept and a timeline for a BBMRI-ERIC Code of Conduct for Health Research, to discuss the needs of patients and Member States, and the perspectives of third countries/international organisations, and to outline the code’s topics and working groups. More information is available at: http://iscintelligence.com/event.php?id=319. While the previous meetings were aimed at discussing the priority issues that need to be addressed by the code and agreeing on its development timeline, a subsequent meeting in Brussels on 26-27 July 2017 brought together the core drafting group to prepare the text of the code. In autumn 2017, this text will be discussed with reference groups and consulted on with the Code of Conduct forum members.

The drafting group for the Code of Conduct for Health Research comprises BBMRI-ERIC (lead), representing CORBEL (the EU project of BMS RIs), ECRIN, representatives from EFPIA, CESSDA, RD-CONNECT, Global Alliance, ESR and others, taking into account social and cultural differences, as well as expertise.

 

BBMRI-ERIC:

BBMRI-ERIC (http://bbmri-eric.eu/) is a pan-European research infrastructure which provides access to quality-controlled human biological samples, such as blood, tissues, cells or DNA, and associated clinical and research data. It aims to establish, operate and develop a pan-European distributed research infrastructure of biobanks and biomolecular resources to facilitate the access to resources as well as facilities and to support high-quality biomolecular and medical research. BBMRI-ERIC comprises 19 member states and one international organisation, making it one of the largest research infrastructures for health research in Europe.

09 Oct 2017

Boosting renovation with an innovative service for home-owners

$
0
0
Energy
Global Europe
Innovation & Enterprise

For building owners, the renovation process can be a hassle, shaped by the ambiguity of the measures to implement. Uncertainty is one of the reasons why the renovation rate continues to linger around 1% and private investments remain limited. Achieving the full market potential of renovation calls for a paradigm shift, where a more service-oriented supply-side together with a deeper awareness on the demand-side play key roles. The BetterHome case study shows how innovative business models can drive energy renovations across Europe.

BetterHome is an industry-driven one-stop-shop model, which has proven successful in boosting demand for holistic energy renovations in Denmark. Since the model was launched in 2014 it was profitable after just three years, with 200 projects in 2016 and is expected to continue its growth. Understanding that renovating a building is a big commitment, this model creates a burden-free experience for the building owner and offers a service that goes beyond replacing building components.

The success of the home-owner-centric business model can be explained by the advanced service-oriented role of the installers. BetterHome trains and guides the installers on how to approach the customer, from the first contact to the finalisation of the process. In support, BetterHome also simplifies and structures the renovation process for the installer, through supportive and innovative digital tools, enabling a better evolution for all involved.

Find out what makes BetterHome a success story and what innovation lies behind it in BPIE’s briefing. An infographic is also available.

09 Oct 2017

European forest owners and managers welcome the 4th European Forest Week and underline the key role of sustainable forest management to provide solutions to societal challenges

$
0
0
Agriculture & Food
Sustainable Dev.
Climate & Environment

Joint Press Release

9 October 2017

 

 

European forest owners and managers welcome the 4th European Forest Week and underline the key role of sustainable forest management to provide solutions to societal challenges

CEPF, Copa and Cogeca and EUSTAFOR today welcome the 4th European Forest Week. The theme of the week, “Forests, our common good”, provides an opportunity to highlight the key role of Europe’s millions of forest owners and managers to provide solutions to some of the biggest challenges facing society today, not least climate change and sustainable development.

The 4th European Forest Week is being celebrated through Europe on 9-13 October 2017, under the theme of "Forests, our common good”.  It is being held in conjunction with Las2017 in Warsaw, Poland (‘las’ means ‘forest’ in Polish) – the Joint Session of the UNECE Committee of Forests and the Forest Industry (COFFI) and the FAO European Forestry Commission (EFC).

On this occasion, Europe’s forest owners and managers would like to highlight how an economically viable and responsible forestry sector contributes to overall societal objectives, like fighting climate change and ensuring a sustainable development.

By balancing the three pillars of sustainability, economic, social and environmental, in their day-to-day management, Europe’s forest owners and managers are providing a multitude of benefits to society. Growing forests clean the air of carbon dioxide, provide areas for recreation and biodiversity and provide a range of ecosystem services as well as a crucial renewable resource that can replace non-renewable materials and energy. Furthermore, forestry contributes to a living countryside, providing jobs and income in Europe’s rural areas.

The 4th European Forest Week once more provides a great opportunity to show the commitment of European forest owners and managers to contribute to a sustainable and productive forestry sector that is able to respond to future challenges and to ever-increasing demands from society.

For more information about the Las2017, please see the conference website.

Read more on European Forest Week here.

For further information, please contact:

CEPF – Confederation of European Forest Owners

Contact: Emma Berglund, emma.berglund@cepf-eu.org, www.cepf-eu.org

COPA and COGECA – European Farmers and European Agri-Cooperatives

Contact: Amanda Cheesley, amanda.cheesley@copa-cogeca.eu, www.copa-cogeca.eu

EUSTAFOR – European State Forest Association

Contact: Piotr Borkowski, piotr.borkowski@eustafor.eu, www.eustafor.eu

Confederation of European Forest Owners (CEPF)

European Forestry House
Rue du Luxembourg 66, B-1000 Bruxelles, Belgium

T: +32 223 92 307

F: +32 221 92 191

Email: office@cepf-eu.org
www.cepf-eu.org

European Family Forestry – sustainability in action!

09 Oct 2017

NIS Gazprom Neft

Sustainable development in the oil and gas sector: How can European leading companies deliver sustainability?

$
0
0
Energy
Little by little, the drive for a sustainability approach has started to shape entire sectors of the global economy, including energy. The signature of the Paris Agreement in December 2015 has been a true landmark for policy-makers, citizens and economic actors. This global commitment is shaping legal frameworks, influencing radical overhauls of companies’ business models and the way we all consume and live. Yet, sustainable development is not an end in itself but rather a continuous process, a permanent walk on unchartered paths. Amongst all, isn’t it the responsibility of the largest companies to show how to enact these commitments, and to open those pathways? And how can those big players concretely act, from adapting their operations to transparently reporting?
 
Sustainability as a strategic business driver
For an economic actor, sustainability is a matter of responsibility: towards citizens, employees, the environment and, ultimately, future generations. Primarily, sustainability demands the protection of nature and biodiversity, especially in sensitive sectors like energy overall and oil and gas in particular. Yet, incorporating it in a company’s principles is not enough, concrete actions need to be undertaken, so it does not remain an idle word. This needs to be done through an integrated approach, entailing the whole range of activity of a business. We, at NIS, apply it in the labeling of products, the transport of goods- (especially when they are dangerous), the management of waste and used materials, emissions of pollutants, the use of water and risk mitigation. This is not an easy option, but it is an opportunity; a business grows by investing and innovating after all and addressing the challenges of energy consumption, energy efficiency and product sustainability is an essential part of future business models. NIS is the leading energy company in South Eastern Europe and sustainability is a key driving force for our business. We are pursuing biofuels as part of our portfolio and in 2016, we have also opened the Amine plant for the purification of natural gas an reducing the “greenhouse gas” effect, the first "HiPACT" plant in Europe and the only one in the world outside Japan!
 
Fulfilling our environmental obligations
Of course, a company based or operating in Europe has tough environmental standards that it needs to fulfill. As a leading Serbian company (Serbia being a member of the Energy Community) and operating in three EU member-states (Hungary, Bulgaria and Romania), NIS fully abides by the relevant legislation. The Clean Energy Package, currently being negotiated in the European Parliament and the Council of the EU and addressing energy efficiency, market design and renewables, directly applies to NIS’s activities. Yet, we believe that it is a matter of responsibility to proactively respond to any new legislation. For instance, the completion of the project “Blending of bio components with diesel fuel in the Oil Refinery Pančevo“ fulfills the requirements on diesel fuel in the transport sector, as future biofuel and bioliquids regulation enters into force in Serbia. The same principles directed how NIS addresses REACH and its pre-registration procedures. Extensive studies and activities were conducted internally to integrate those requirements, which was welcomed with a positive decision on the registration of substances from the European Chemicals Agency (ECHA). More generally, responsibility has been our drive to systematically implement measures to protect human health and the environment against risks arising from the use of chemical products.
 
Social responsibility as a core principle
Genuine dedication to sustainable development also translate into our social actions. The development of the communities where we do business is one of NIS’s strategic objectives. Many projects have been developed on a local scale, benefiting the countries and the communities where we have been working. Within the Public Competition Together for the Community, in 2016 NIS supported 106 best projects in the field of sports, culture, environmental protection, science and social protection, whose implementation contributes to the development of local communities, enables easier functioning of numerous institutions and improves the activities of cultural, educational and sports institutions.
 
This approach also applies to our employees, protecting their occupational health and safety with the highest standards, and valuing their skills and inputs. In May 2016, we have become the signatory of “CEO statements on the Women’s Empowerment Principles (WEPs)” and a champion of the “Salary Management System” of this initiative, created together with the UN Global Compact, UN Women and leading world companies. By doing so, our company has committed to apply seven principles aiming at achieving better financial results by increasing talent visibility and labor productivity, ensuring long-term competitiveness through the strategic development of the women’s staff and promoting gender equality in its own and social environment.
 
The list is long but not exhaustive and we do see this as an ongoing process. For the 7th year in a row, NIS has released a Sustainable Development Report, describing our initiatives, their status and our targets. Reporting is not easy; it takes a lot of commitment and conviction but we, as regional leader, believe that it is our responsibility to report, to initiate and to act as pathfinder. It is a sincere, integrated approach for sustainability, on all levels.
09 Oct 2017

Forum: Recycling Industry and Circular Economy - up to the Challenge

$
0
0
Sustainable Dev.
 
 
 
 
 
 
 
 
 
 
In December 2015, the European Commission presented a new circular economy package that will impact a wide range of sectors, especially the recycling sector. This package has set various targets in terms of recycling but also has introduced Life cycle thinking and measurement tools such as PEF (currently under pilot phase). By turning waste into new resources, recycling enables the circular economy.
 
FEDEREC carried out a study with the ADEME about CO2 and energy savings thanks to recycling. This study is accompanied, for the operational aspect, by a software allowing the calculation of CO2 and energy saving per materials. It was published in May 2017 in Paris and received a very wide welcome by French press and stakeholders.
 
Beyond the precise measurement of the environmental benefits of recycling, this study makes possible the link between circular economy and climate change policies adopted in the Paris Agreement.
 
This initiative is very much appreciated by the industry and meet the work done by DG environment in the PEF/OEF (product environmental footprint initiative) pilot phase.
 
This EURACTIV high-level forum takes place on October 17 at the EURACTIV network office and will address the following issues:
  • What policy framework is needed to benefit from CO2 and energy savings generated by recycling?
  • What is the relation between PEF and the FEDEREC study?
  • How does recycling contribute to bridge the EU’s circular economy and climate change policies?
  • How the methodology can be used by operators in their day-today business?
  • Can this study be used as best practice across the EU?

Discussion contributors:

Karmenu VellaCommissioner (video)
Angélique DelahayeMember of the European Parliament
Ms An De SchryverDG Environment
Jean-Philippe CarpentierPresident of FEDEREC
Manuel Burnand, Chief Executive Officer of FEDEREC
Jean-Charles Caudron, Head of the Product and Material Efficiency Department at ADEME
 
 
 
Moderator
Frédéric Simon, Energy and Environment Editor, EURACTIV
 
Programme
17:00 – 17:30 Registration
17:30 – 18:30 Keynote speech and panel discussion
18:30 – 19:00 Open discussion
19:00 – 20:00 Reception
 
 
For more information, please contact:
 
Adrien Dufour
+33 1 75 61 25 02
09 Oct 2017

FEDEREC - Fédération Professionnelle des Entreprises du Recyclage

CS Mare

Medicines for Europe announces new President, launches Access to Medicines campaign

$
0
0
Health & Consumers

Warsaw, 10 October 2017

  • Today Marc-Alexander Mahl will take over the Presidency of Medicines for Europe from Jacek Glinka.
  • The new President announced his priority to increase Access to Medicines for patients starting with a new campaign.
  • The campaign calls on health ministers to realise the potential of generic, biosimilar and value added medicines, building on the EU Health Council Conclusions of June 2016.
 
The newly elected President of Medicines for Europe – Marc-Alexander Mahl – launched the “Access to Medicines: Better Care for More Patients” campaign which calls on health ministers to fully embrace generic, biosimilar and value-added medicines to improve the sustainability of healthcare systems across Europe.
 
Dr. Mahl takes over the Presidency of Medicines for Europe for 2 years. As Executive Vice President Business Unit Generic Drugs at Fresenius Kabi, Marc-Alexander Mahl chaired the Hospital Sector at Medicines for Europe. A physician by training, he completed his specialization in transfusion medicine and blood banking in 2001, the year he also joined Fresenius Kabi. He also holds an Executive MBA from INSEAD.
 
Today, in Warsaw, Marc-Alexander Mahl explained: “European healthcare is under financial constraint with many patients struggling to get access to treatments. The increasing overall cost of healthcare will force policy-makers to make difficult and unpopular choices about how best to allocate resources. Yet there is a very simple and obvious way to ensure access while managing healthcare budgets: to promote generic, biosimilar and value added medicines use by patients, medical professionals and pharmacists.” The new campaign will provide compelling data and proposals to help policy-makers and stakeholders improve access to medicines. In particular, the campaign will help policy-makers encourage competition in complex, specialty medicine markets where there are tremendous opportunities to increase access, spend resources more efficiently and improve overall care for patients.
 
 
About Medicines for Europe
Medicines for Europe represents the generic, biosimilar and value added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership. Its members employ 160,000 people at over 350 manufacturing and R&D sites in Europe, and invest up to 17% of their turnover in medical innovation. Medicines for Europe member companies across Europe are both increasing access to medicines and driving improved health outcomes. They play a key role in creating sustainable European healthcare systems by continuing to provide high quality, effective generic medicines, whilst also innovating to create new biosimilar medicines and bringing to market value added medicines, which deliver better health outcomes, greater efficiency and/or improved safety in the hospital setting for patients. For more information please follow us at www.medicinesforeurope.com and on Twitter @medicinesforEU.
 
Medicines for Europe Communications:
Andrea Bedorin
10 Oct 2017

EU buildings law must ensure uptake of charging infrastructure for Electric Vehicles

$
0
0
Energy

Brussels, 10/10/2017

Wednesday’s MEP vote on the revision of the Energy Performance of Buildings Directive (EPBD) must ensure that European buildings contribute to unlocking the potential of electric mobility through the deployment of charging infrastructure. This is crucial to speed up the market penetration of electric vehicles and the decarbonisation of the road transport sector.

“The European strategy for decarbonisation of buildings must reflect the importance of decarbonised electricity in the energy transition,” said EURELECTRIC Secretary General, Kristian Ruby. “The integration of electric vehicle (EV) charging infrastructure in the revision of this Directive is crucial to speed up the market penetration of electric vehicles and thereby the decarbonisation of the road transport sector.”

EURELECTRIC calls on the European Parliament to adopt these key measures:

  • EV charging points should also be installed in public parking lots and buildings of mixed use. Support Amendments 396, 397, 399 and 406.
  • Smart charging points are key enablers for sector coupling. Make them the standard.
  • All tenants and co-owners should have the right to install a charging point. Support Amendment 407.
  • Electric vehicles are not only for big companies. SMEs should not be excluded from the benefits of e-mobility. Support Amendments 365 and 366.

Looking a step further, Europe must seize the opportunity and shape the future of mobility in the upcoming Mobility Package. EURELECTRIC calls on the Commission to:

  • Include a definition of “clean vehicles” in the revised Clean Vehicles Directive, based on a threshold of below 50gCO2 emission/km at tailpipe.
  • Implement strict and coherently tested emission standards for light duty vehicles and heavy duty vehicles, as well as separate targets for the take up of zero emission vehicles.
  • Unlock smart charging, which will offer significant benefits both to the electricity system as well as to the final customers.

EURLECTRIC’s voting recommendations on the revision of the Energy Performance of Buildings Directive can be found here.

ENDS

Press Contact:

Anamaria OLARU, Press & Media Relations

tel: +32 (0)483 45 92 42

e-mail: aolaru@eurelectric.org

 

10 Oct 2017
Viewing all 7168 articles
Browse latest View live




Latest Images